Kardium Revenue and Competitors

CAN

Location

$325M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kardium's estimated annual revenue is currently $90.1M per year.(i)
  • Kardium's estimated revenue per employee is $217,000
  • Kardium's total funding is $325M.

Employee Data

  • Kardium has 415 Employees.(i)
  • Kardium grew their employee count by 19% last year.

Kardium's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, EngineeringReveal Email/Phone
3
VP, Product ManagementReveal Email/Phone
4
VP, Regulatory Affairs & Quality AssuranceReveal Email/Phone
5
VP TalentReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Director, Quality EngineeringReveal Email/Phone
8
Director Intellectual PropertyReveal Email/Phone
9
Project Manager - ClinicalReveal Email/Phone
10
Senior Manager, TalentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30M155-5%$132.7MN/A
#2
$10.9M70-5%$2MN/A
#3
$15.7M1015%N/AN/A
#4
$11M718%N/AN/A
#5
$123.9M571-11%$94.5MN/A
#6
$22.5M3200%$845.8MN/A
#7
$9.8M41-68%$494.1MN/A
#8
$443.8M82111%$371.2MN/A
#9
$33.6M21719%N/AN/A
#10
$100M4618%$871.5MN/A
Add Company

What Is Kardium?

Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation. .

keywords:N/A

$325M

Total Funding

415

Number of Employees

$90.1M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kardium News

2022-04-13 - Pulsed Field Ablation Treats AF With Few Complications

... Intershunt, Javelin, Kardium, Keystone Heart, LuxMed, Manual Surgical Sciences, Medlumics, Middlepeak, Newpace, Nuvera, Sirona Medical,...

2022-04-13 - Kardium's Globe System Begins Clinical Trial at St. Paul's ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the...

2021-01-26 - Kardium Raises $115M in Financing

Kardium Inc., a Vancouver, British Columbia, Canada-based developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, raised US $115m in financing. The round was led by Fidelity Management & Research Company LLC., with participation from funds and accounts advi ...

2021-01-25 - Kardium Announces $115M in New Financing for Innovative Atrial Fibrillation Treatment

Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by ...

2021-01-25 - BC’s Kardium raises $115 million USD for heart device technology

Kardium, a British Columbia-based medical device company, has secured $115 million USD from Fidelity Management and T. Rowe Price Associates. The round was led by United States-based Fidelity Management, with T. Rowe Price Associates providing follow-on investment after leading Kardium’s $40 mi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$108.9M415N/AN/A
#2
$93.4M415-4%N/A
#3
$93.4M415-1%N/A
#4
$35M4157%N/A
#5
$72.8M4162%N/A